Você procurou por: panitumumab (Inglês - Francês)

panitumumab
panitumumab

each vial contains 200 mg panitumumab.
chaque flacon contient 200 mg de panitumumab.

each vial contains 100 mg of panitumumab.
chaque flacon contient 100 mg de panitumumab.

what is vectibixtm (panitumumab) used for?
À quoi sert vectibixmc (panitumumab)?

it contains the active substance panitumumab.
son principe actif est le panitumumab.

each ml of concentrate contains 20 mg panitumumab.
chaque ml de solution à diluer contient 20 mg de panitumumab.

vectibix 20 mg/ml sterile concentrate panitumumab
vectibix 20 mg/ml solution stérile à diluer panitumumab

the active substance is panitumumab 20 mg/ ml.
la substance active est le panitumumab 20 mg/ ml.

vectibix 20 mg/ ml sterile concentrate panitumumab iv
vectibix 20 mg/ ml solution stérile à diluer panitumumab iv

there was an increase in mortality in the panitumumab arm.
une augmentation de la mortalité dans le bras panitumumab a été observée.

vectibix 20 mg/ml concentrate for solution for infusion panitumumab
vectibix 20 mg/ml solution à diluer pour perfusion panitumumab

colourless solution that may contain visible amorphous panitumumab particles.
solution incolore pouvant contenir des particules visibles amorphes de panitumumab.

panitumumab may impact the ability of a woman to become pregnant.
le panitumumab peut affecter la capacité d’une femme à être enceinte.

the active substance in vectibix, panitumumab, is a monoclonal antibody.
le principe actif de vectibix, le panitumumab, est un anticorps monoclonal.

lactation it is unknown whether panitumumab is excreted in human breast milk.
allaitementle passage du panitumumab dans le lait maternel n'est pas connu.

panitumumab does not seem to work in tumour cells that contain mutated ras genes.
le panitumumab ne semble pas agir sur les cellules tumorales qui contiennent des gènes ras mutés.

because human igg is secreted into human milk, panitumumab might also be secreted.
l’igg humaine étant sécrétée dans le lait maternel, le panitumumab pourrait l’être également.

this may be due to patients receiving panitumumab after progression among those randomized to bsc.
ceci peut être lié à l’ administration de panitumumab après progression de la maladie des patients initialement randomisés dans le bras sp.

no pre- and post-natal development animal studies have been conducted with panitumumab.
aucune étude animale du panitumumab sur le développement pré- et postnatal n’a été menée.

vectibixtm (20 mg/ml, panitumumab) is presented as a solution for infusion.
vectibixmc (20 mg/ml, panitumumab) est offert en solution pour perfusion.